XBI - SPDR S&P Biotech ETF (USD) (US78464A8707)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Alle auswählen Alle zurücksetzen

Speichern Schließen

(%)

US78464A8707

XBI ISIN

Exchange Traded Funds (ETF)

Fondstyp

SPDR State Street Global Advisors

Anbieter

152,05 USD

NAV pro Aktie | 16/07/2026

31/01/2006

Startdatum

4 Wiederholungen pro Jahr

Ausschüttung von Dividenden

CEOILS

CFI

XBI

Ticker

Formed

Status

Equity

Investitionsobjekt

Biotech

Sektor

USA

Geographie

S&P Biotechnology Select Industry Index

Benchmark

0.35 %

Gesamtkostenquote

10.209,94 Mio. USD

Gesamtes Fondsvermögen | 16/07/2026

10.209,94 Mio. USD

Aktien-Anlageklasse Volumen | 16/07/2026

Nein

UCITS

1 / 3 (11/09/2015)

Split

Rendite auf 16/07/2026, NYSE Arca

YTD

5,06 %
1M

-7,93 %
3M

1,65 %
6M

11,2 %
1J

62,15 %
3J

51,47 %
5J

0,91 %
10J

143,19 %

Zum Börsenpreis einschliesslich Einkommenszahlungen

Letzte Daten zum

Zum Vergleichen hinzufügen

Kurse (XBI)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

100 000

Aktien

175 910

ETF & Funds

100 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

Bond-Screener
Watchlist
Excel-Add-In

Zugang erhalten

Kurs-Dynamik

Fund profile

The SPDR S&P Biotech ETF seeks to replicate as closely as possible the price and yield performance of the S&P Biotechnology Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the biotechnology sector

XBI profile

The SPDR S&P Biotech ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 31.01.2006 with unique ISIN - US78464A8707. Main exchange is NYSE Arca and ticker symbol is XBI. The total expense ratio is 0.35%. The SPDR S&P Biotech ETF (USD) pays dividends 4 time(s) per year.

Struktur XBI auf 15/07/2026

Struktur in Excel herunterladen

Wertpapier	Wertpapier
APOGEE THERAPEUTICS INC	1,55%
ERASCA INC	1,52%
MODERNA INC	1,42%
KYMERA THERAPEUTICS INC	1,39%
TWIST BIOSCIENCE CORP	1,31%
VIKING THERAPEUTICS INC	1,3%
SPYRE THERAPEUTICS INC	1,3%
ORUKA THERAPEUTICS INC	1,29%
CG ONCOLOGY INC	1,27%
PRAXIS PRECISION MEDICINES I	1,27%
DIANTHUS THERAPEUTICS INC	1,25%
MIRUM PHARMACEUTICALS INC	1,23%
NATERA INC	1,22%
PROTAGONIST THERAPEUTICS INC	1,22%
RHYTHM PHARMACEUTICALS INC	1,22%
REVOLUTION MEDICINES INC	1,22%
COGENT BIOSCIENCES INC	1,2%
VAXCYTE INC	1,19%
RELAY THERAPEUTICS INC	1,18%
CYTOKINETICS INC	1,18%
ROIVANT SCIENCES LTD	1,17%
BRIDGEBIO PHARMA INC	1,17%
SCHOLAR ROCK HOLDING CORP	1,17%
TRAVERE THERAPEUTICS INC	1,16%
TG THERAPEUTICS INC	1,16%
INSMED INC	1,14%
ALKERMES PLC	1,13%
ULTRAGENYX PHARMACEUTICAL IN	1,12%
MADRIGAL PHARMACEUTICALS INC	1,12%
VERA THERAPEUTICS INC	1,08%
SUMMIT THERAPEUTICS INC	1,08%
KRYSTAL BIOTECH INC	1,07%
SELLAS LIFE SCIENCES GROUP I	1,06%
REGENERON PHARMACEUTICALS	1,06%
VERTEX PHARMACEUTICALS INC	1,05%
INCYTE CORP	1,04%
ABBVIE INC	1,04%
GILEAD SCIENCES INC	1,04%
HALOZYME THERAPEUTICS INC	1,03%
PTC THERAPEUTICS INC	1,03%
NEUROCRINE BIOSCIENCES INC	1,02%
GRAIL INC	1,02%
AMGEN INC	1,01%
EXELIXIS INC	1,01%
BIOMARIN PHARMACEUTICAL INC	1%
BEAM THERAPEUTICS INC	1%
CRISPR THERAPEUTICS AG	0,99%
CELCUITY INC	0,99%
ACADIA PHARMACEUTICALS INC	0,99%
IMMUNOVANT INC	0,99%
ARROWHEAD PHARMACEUTICALS IN	0,97%
BIOGEN INC	0,97%
DYNE THERAPEUTICS INC	0,96%
UNIQURE NV	0,94%
UNITED THERAPEUTICS CORP	0,93%
IMMUNITYBIO INC	0,93%
ALNYLAM PHARMACEUTICALS INC	0,92%
BIOCRYST PHARMACEUTICALS INC	0,87%
VERACYTE INC	0,86%
TANGO THERAPEUTICS INC	0,84%
IDEAYA BIOSCIENCES INC	0,82%
SYNDAX PHARMACEUTICALS INC	0,8%
ARCUTIS BIOTHERAPEUTICS INC	0,78%
DENALI THERAPEUTICS INC	0,77%
AGIOS PHARMACEUTICALS INC	0,77%
SAREPTA THERAPEUTICS INC	0,75%
CELLDEX THERAPEUTICS INC	0,75%
MINERALYS THERAPEUTICS INC	0,74%
INTELLIA THERAPEUTICS INC	0,72%
VIRIDIAN THERAPEUTICS INC	0,72%
IONIS PHARMACEUTICALS INC	0,71%
RECURSION PHARMACEUTICALS A	0,7%
DISC MEDICINE INC	0,7%
ARCUS BIOSCIENCES INC	0,7%
IOVANCE BIOTHERAPEUTICS INC	0,66%
IMMUNOME INC	0,66%
ADMA BIOLOGICS INC	0,65%
KODIAK SCIENCES INC	0,61%
NOVAVAX INC	0,61%
PALVELLA THERAPEUTICS INC	0,6%
NURIX THERAPEUTICS INC	0,56%
BIOHAVEN LTD	0,54%
VERICEL CORP	0,54%
ABSCI CORP	0,49%
MONTE ROSA THERAPEUTICS INC	0,48%
HYPERLIQUID STRATEGIES	0,46%
VIR BIOTECHNOLOGY INC	0,46%
STOKE THERAPEUTICS INC	0,45%
TYRA BIOSCIENCES INC	0,43%
CAPRICOR THERAPEUTICS INC	0,43%
ANAPTYSBIO INC	0,42%
CORVUS PHARMACEUTICALS INC	0,42%
CULLINAN THERAPEUTICS INC	0,41%
ANNEXON INC	0,39%
ZENAS BIOPHARMA INC	0,38%
ARDELYX INC	0,38%
AVALO THERAPEUTICS INC	0,36%
INHIBRX BIOSCIENCES INC	0,35%
ORIC PHARMACEUTICALS INC	0,35%
PRECIGEN INC	0,35%

Alle anzeigen Verstecken

Andere - %